10.41
+0.18
+(1.71%)
As of 11:36:00 AM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARRETT ELIZABETH A Chief Executive Officer | Conversion of Exercise of derivative security | Jan 31, 2023 | 326,691 |
| COHEN FREDERICK E. M.D. PH.D. Director | Stock Award(Grant) | Jul 26, 2023 | -- |
| KIM DONG Chief Financial Officer | Conversion of Exercise of derivative security | Sep 9, 2024 | 37,753 |
| SCHOENBERG MARK Officer | Conversion of Exercise of derivative security | Sep 9, 2024 | 145,091 |
| SMITH JASON DREW General Counsel | Conversion of Exercise of derivative security | Sep 9, 2024 | 25,226 |
Related Tickers
MGTX MeiraGTx Holdings plc
6.30
+1.45%
KALV KalVista Pharmaceuticals, Inc.
8.96
+4.06%
SWTX SpringWorks Therapeutics, Inc.
37.35
+3.29%
ADCT ADC Therapeutics SA
1.7350
-1.98%
SLDB Solid Biosciences Inc.
3.2100
0.00%
RGNX REGENXBIO Inc.
7.79
-1.14%
PLRX Pliant Therapeutics, Inc.
11.13
+1.92%
NUVB Nuvation Bio Inc.
2.5148
-0.21%
ATXS Astria Therapeutics, Inc.
7.58
+2.29%
DAWN Day One Biopharmaceuticals, Inc.
12.75
+4.42%